Global Cancer Immunotherapy Market to reach a market size of $128.3 billion by 2024

According to a new report Global Cancer Immunotherapy Market, published by KBV research, The Global Cancer Immunotherapy Market size is expected to reach $128.3 billion by 2024, rising at a market growth of 14.3% CAGR during the forecast period.

The US market would dominate the North America Cancer Immunotherapy Colorectal Cancer Market by 2024; growing at a CAGR of 11.4 % during the forecast period. The Canada market is expected to witness a CAGR of 14% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 13.3% during (2018 - 2024).

The Monoclonal Antibodies market dominated the Global Cancer Immunotherapy Market by Technology 2017, thereby, achieving a market value of $61,048.9 million by 2024. The Cytokines & Immunomodulators market is expected to witness a CAGR of 12.8% during (2018 - 2024). Additionally, The Other Technology market is expected to witness highest CAGR of 15.2% during (2018 - 2024).

The Lung Cancer market dominated the Global Cancer Immunotherapy Market by Application 2017, growing at a CAGR of 13 % during the forecast period. The Melanoma market is expected to witness a CAGR of 16% during (2018 - 2024). Additionally, The Head & Neck Cancer market is expected to witness highest CAGR of 14.9% during (2018 - 2024).

Full Report: https://www.kbvresearch.com/cancer-immunotherapy-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of AstraZeneca, Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Bayer Ag, Immunomedics Inc., Novartis AG, F. Hoffmann-La Roche Ltd

Global Cancer Immunotherapy Market Segmentation

By Technology

• Monoclonal Antibodies,
• Cytokines & Immunomodulators
• Other technology

By Application

•  Lung cancer
•  Breast cancer
• Colorectal
•  Prostate cancer
• Head & Neck cancer
• Other application.

By End User

• Hospitals
• Clinics
• Other End User

 By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• AstraZeneca
• Amgen Inc.
• Eli Lilly and Company
• Merck & Co., Inc.
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Bayer Ag
• Immunomedics Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd

Unique Offerings from KBV Research

• Exhaustive coverage  
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

North America Cancer Immunotherapy Market (2018-2024)

Europe Cancer Immunotherapy Market (2018-2024)

Asia Pacific Cancer Immunotherapy Market (2018-2024)

LAMEA Cancer Immunotherapy Market (2018-2024)